02137.HK
Brii Biosciences Limited
HKSE · Healthcare · Biotechnology · CN
HKD 0.93
+2.20%Margins
Gross margin
86.9%
EBITDA margin
-1195.2%
EBIT margin
-1222.5%
Net margin
-1057.3%
FCF margin
-898.0%
-24.5%
Return on equity
-24.7%
Return on assets
-28.3%
Return on invested capital
0.02x
Asset turnover
-HKD 533.1M
Cash from operations
HKD 2.86
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026